Mr. Asarpota will lead Augmedics’ global finance organization and will be responsible for accounting, treasury, financial planning and analysis, tax and investor relations. His appointment completes Augmedics’ senior leadership team.
He previously held CFO and executive vice president roles at NuVasive and ApiJect Systems America, which focuses on how medicines and vaccines are filled. At ApiJect, he was also head of technology.
Augmedics is a surgical imaging company known for its augmented reality Xvision spine system.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.